research use only
Cat.No.S3938
| Related Targets | Bcl-2 Caspase PD-1/PD-L1 Ferroptosis p53 Synthetic Lethality STAT TNF-alpha Ras KRas |
|---|---|
| Other Apoptosis related Inhibitors | Importazole Pitstop 2 Genipin Plumbagin 6-Gingerol Crocin Sodium propionate Colcemid Euphorbia factor L3 CWI1-2 hydrochloride |
|
In vitro |
DMSO
: 62 mg/mL
(201.08 mM)
Ethanol : 25 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 308.33 | Formula | C19H16O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 33171-05-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1=CC(=CC=C1C=CC(=O)CC(=O)C=CC2=CC=C(C=C2)O)O | ||
| In vitro |
Bisdemethoxycurcumin (BDMC), a demethoxy derivative of curcumin, is a natural substance found in the turmeric root. It inhibits the growth of gastric cancer SGC 7901 cells in a dose‑dependent manner. This compound arrests the cell growth in G1 phase and thus, cells could not reach S phase and complete the cycle.
|
|---|---|
| In vivo |
Bisdemethoxycurcumin (BDMC) may promote apoptosis in tumors via mitochondrial modulation. It inhibits tumor growth and caused an increase in body weight of gastric adenoadenocarcinoma xenograft model.
|
References |
|
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05542394 | Completed | Plasma Levels of Different Curcuminoids Preparations |
University of Jordan|Nutritional Fundamentals for Health |
September 20 2022 | Not Applicable |
| NCT01982734 | Completed | Pharmacokinetics of New Curcumin Formulations|Safety of New Curcumin Formulations |
University of Hohenheim|German Federal Ministry of Education and Research |
November 2012 | Early Phase 1 |
| NCT01925287 | Completed | Pharmacokinetics of Novel Curcumin Formulations|Safety of Novel Curcumin Formulations |
University of Hohenheim|German Federal Ministry of Education and Research |
October 2011 | Early Phase 1 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.